OVERLAND PARK, Kan. and LUGANO, Switzerland, Dec. 12, 2016 -- Black & Veatch and Casale SA today announced the signing of a global licensing and cooperation agreement that designates Black & Veatch as a licensee for Casale’s innovative fertilizers, melamine, methanol and related chemical technologies. The companies are focused on addressing significant demand worldwide for chemical, fertilizer and industrial plant development. Demand is being driven primarily by global population growth and lower natural gas prices.
|
|||
The licensing agreement builds on the successful joint execution of multiple projects by Black & Veatch and Casale during the past 30 years. Under the terms of the agreement, Black & Veatch is granted a global license to engineer and build chemical (i.e. methanol and melamine) and fertilizer (i.e. ammonia, urea, nitric acid, ammonium nitrate, urea ammonium nitrate, superphosphates and complex fertilizers) plants that use Casale technologies.
Black & Veatch and Casale now offer a global one-stop engineering, procurement and construction (EPC) solution for pursuing and participating in the proposal and execution of projects. Services also include start-up, operation and maintenance activities while leveraging Casale’s technologies.
“Black & Veatch has more than 50 years of experience in successful plant development in commercial fertilizer process technologies and project execution,” said Doug Miller, Vice President & Managing Director of Technology for Black & Veatch’s Oil & Gas business. “Casale brings its global leadership in fertilizers, melamine, methanol and related technologies. This agreement offers integrated innovative low-cost solutions for all of our clients’ needs across the life of a project from conception to plant start-up and ongoing maintenance and operation support. ”
“Casale has 95 years of experience in developing technologies in the fields of fertilizer, melamine, methanol and syngas generation, and in the design of the related plants, and currently holds a leading presence in such fields,” said Ermanno Filippi CTO of Casale SA. “This agreement allows us to further expand our offering in the global EPC marketplace by building on our longstanding and successful relationship with Black & Veatch.”
Editor’s Notes:
- Casale is an engineering leader in chemical, petrochemical, fertilizer and other industrial plants and has extensive proprietary technology for the production of ammonia, urea, methanol, melamine and nitric acid, among other products.
- Black & Veatch has completed more than 50 projects involving fertilizer plants with production ranging from 50 to 2,500 metric tons per day. The company’s projects have involved planning studies, revamps, and ammonia storage and terminal facilities. Black & Veatch also has nitric acid, urea and urea ammonium experience.
About Black & Veatch
Black & Veatch is an employee-owned, global leader in building critical human infrastructure in Energy, Water, Telecommunications and Government Services. Since 1915, we have helped our clients improve the lives of people in over 100 countries through consulting, engineering, construction, operations and program management. Our revenues in 2015 were US$3.0 billion. Follow us on www.bv.com and in social media.
Media Contact Information:
GEORGE MINTER | +1 913-458-8001 P | +1 913-972-8811 M | [email protected]
24-HOUR MEDIA HOTLINE | +1 866-496-9149
About Casale SA
Casale SA is a privately owned Swiss Company, wholly owned by CASALE HOLDING, with headquarters in Lugano, Switzerland. Casale, the Swiss global leader in ammonia, urea, methanol, melamine, nitric acid, nitrate and phosphate technologies is, since 1921, a global provider of integrated solutions for the production of fertilizers and chemicals from syngas. For more information, visit www.casale.ch
Media Contact Information:
Casale SA | Lorenzo Pennino, head of sales department | Tel. +41 91 6419237 | e-mail: [email protected]


Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery 



